PNC-27 5 mg – Anti-Cancer Research Peptide by Peptide Hubs
PNC-27 is a synthetic peptide composed of a p53-derived sequence linked to a membrane residency domain. It has been extensively studied in preclinical research for its highly selective cytotoxic effects on cancer cells without affecting healthy tissue. Offered by Peptide Hubs in a 5 mg/vial formulation (2 mL vial), PNC-27 is strictly intended for research use and is not approved for human consumption or therapeutic applications.
What is PNC-27?
PNC-27 is engineered to mimic a segment of the p53 tumor suppressor protein, combined with a membrane translocation sequence. This design enables it to bind to HDM-2 (Human Double Minute-2), a protein overexpressed in many cancer types, forming pores in cancer cell membranes and causing selective lysis. Research has shown that it targets malignant cells while sparing healthy ones, making it a fascinating subject in the field of experimental oncology.
As outlined in this PubMed-indexed study, PNC-27 has demonstrated promising results in vitro and in murine models by inducing necrosis of tumor cells through membrane disruption. While human studies are lacking, its tumor-specific affinity continues to fuel interest in labs studying novel anti-cancer pathways.
Mechanism of Action
PNC-27 works by targeting the HDM-2 receptor, which is upregulated in a variety of tumor types. Upon binding, it integrates into the cell membrane and initiates pore formation, ultimately leading to necrosis. This action is distinctly different from traditional chemotherapeutic agents, which affect both healthy and cancerous cells indiscriminately.
Technical Details
Peptide Type
Chimeric p53-Derived Peptide
Peptide Sequence
PPLSQETFSDLWKLLKKWKMRRNQFWVKVQRG
Peptide Length
32 Amino-Acid Residues
Terminal Form
H-PPLSQETFSDLWKLLKKWKMRRNQFWVKVQRG-OH
p53-Derived Domain
Human p53 Residues 12–26
Leader Domain
17-Residue Membrane Residency Peptide (MRP)
Molecular Formula
C₁₈₈H₂₉₃N₅₃O₄₄S
Molecular Weight
4032 g/mol
Research Target
Membrane-Associated HDM-2 / MDM-2
Research Status
Experimental / Preclinical
Dosage & Usage Guidelines
In experimental setups, PNC-27 is typically administered at dosages ranging from 2 mg to 5 mg per week. It is often reconstituted with bacteriostatic water and delivered via intratumoral or systemic routes in research animals. It is not for human use and is labeled accordingly for laboratory settings only.
Stacking for Advanced Research Models
Researchers exploring synergistic peptide protocols may consider combining PNC-27 with compounds such as:
- Thymosin Alpha-1 – for immune modulation in tumor models
- Ipamorelin – for GH axis support in long-term research
- Melanotan 2 – being studied for pigmentation and photoprotection in skin cancer models
- CJC-1295 no DAC – a GH secretagogue for metabolic cofactor studies
Potential Side Effects (Observed in Research Models)
While no systemic toxicity has been noted in preclinical data, researchers have reported local reactions at injection sites in animal studies. Proper lab protocol and biosafety handling are essential. No known hepatotoxicity or cardiovascular strain has been reported in published literature to date.
USA Domestic Delivery & Research Use Disclaimer
Peptide Hubs ensures quick and discreet USA domestic shipping of PNC-27 5 mg. This product is for licensed laboratories, research professionals, and educational institutions. For alternative therapeutic peptides, explore our catalog which includes BPC-157 and GHK-Cu.
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery
This product is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
What to Expect
- ✔ Orders are processed after payment confirmation
- ✔ USA Domestic shipping is typically faster when local stock is selected
- ✔ International orders include tracking, though update frequency may vary by destination
- ✔ Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Peptide Hubs presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.
After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
Frequently Asked Questions
Is PNC-27 safe for human use?
No, PNC-27 is strictly for research purposes and not approved for human use by any regulatory agency.
What is the main application of PNC-27 in research?
It is primarily studied for its selective cytotoxic effects on cancer cells, particularly those overexpressing HDM-2 receptors.
Does PNC-27 cause harm to healthy cells?
Current preclinical data suggest PNC-27 selectively targets cancer cells, leaving healthy tissue largely unaffected.
How should PNC-27 be stored?
It should be stored in a cool, dry place. Once reconstituted, it should be refrigerated and used within a few days according to lab protocols.
No reviews found
Please log in to write PNC-27 5 mg review.